Together with our experiments utilising mouse models, these data reveal that MCL-1 function in breast cancer stem cells in vitro and in tumour survival in vivo is due to its anti-apoptotic function that is targetable by BH3-mimetic drugs. This evidence concerns the gene MCL1 and breast cancer.